Arcade Therapeutics

📍 New York, United States🗓 Founded 2019👥 10 employees💰 Last funded Jul 2022
Arcade Therapeutics is a science-first game studio dedicated to treating mental illness by combining the most cutting edge cognitive neuroscience with engaging games. Our NYC-based team includes leaders in clinical research, consumer products, game development, and healthcare strategy. Arcade was named a 2024 Digital Health NY 100 Company, and was named to the Global HealthTech 250 by Galen Growth. Arcade’s non-prescription anxiety game, StarStarter, is available to manage symptoms of anxiety for ages 13+. The company is also pursuing FDA submissions for its pipeline of therapeutic games targeting indications including social anxiety disorder, generalized anxiety disorder, major depressive disorder, alcohol use disorder as well as mental health conditions related to pregnancy and multiple sclerosis. With Arcade Connect, we deliver these treatments integrated into healthcare workflows, allowing for seamless distribution from provider to patient, reporting and support for reimbursement. Please connect with us to learn more and become a partner as we work together to change the game in mental health.
2
Total investors
0
Early stage
2
Mid stage
0
Late stage
2019
Founded
Investor geography2 countries
Andorra
1
United States
1
Frequently asked questions
Who invested in Arcade Therapeutics?
Arcade Therapeutics has 2 investors on record on gritt.io, 2 mid-stage.
When did Arcade Therapeutics last raise funding?
The most recent investment in Arcade Therapeutics recorded on gritt.io was in July 2022.
When was Arcade Therapeutics founded?
Arcade Therapeutics was founded in 2019.
What industry is Arcade Therapeutics in?
Arcade Therapeutics operates in Mental Health Care. Find similar Mental Health Care investors on gritt.io.
Where is Arcade Therapeutics based?
Arcade Therapeutics is headquartered in New York, United States.